INCLUSIO Aktie

 

NEW YORK CITY, NY / ACCESS Newswire / May 29, 2025 / Freedom Holding Corp. (NASDAQ:FRHC), a diversified multinational financial services firm, announced today that it has been selected for inclusio......

Folgendes Instrument wird heute EX Kapitalmassnahme gehandelt. Aus technischen Gruenden wird der EX-Indikator heute nicht angezeigt. The following instrument is traded ex capital adjustment today. Due to technical reasons the EX-indicator will not be displayed today. ISIN Short Code Name BE0974374069 9ZS Inclusio S.A...

Toronto, Ontario and Haifa, Israel--(Newsfile Corp. - March 10, 2025) - NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) ("NurExone" or the "Company") is proud to announce its inclusio......

WASHINGTON--(BUSINESS WIRE)--Today, ACRO announced the seven clinical research sites that will receive grant funding as part of the ACRO Diversity and Inclusion Site Resource Grants Program. The site grant awardees include: Brooklyn Clinical Research – New York K2 Medical Research – Florida Nebraska Cancer Specialists – Nebraska Preferred Primary Care Physicians – Pennsylvania Randomize Now – Georgia Smart Cures Clinical Research – California Superior Clinical Research – North Carolina With this pilot project, ACRO will support seven 12-month programs, serving as a platform to incubate innovative strategies for improving diverse enrollment in clinical research. “We hope that ACRO's D&I Site Resource Grants Program will help to elevate these seven projects as proof-of-concept initiatives to show the broader industry that a small investment can go a long way toward improving representation in clinical trials,” said Tafoya Hubbard, Grants Program Manager, ACRO. ACRO's Diversity & Inclusio...